North America Neurostimulation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers North America Nerve Stimulators Market Analysis and is segmented by Device Type (Implantable Devices (Vagus Nerve Stimulators, Spinal Cord Stimulators, Deep Brain Stimulators, Gastric Electric Stimulators, and Other Implantable Devices) and External Devices (Transcranial Magnetic Stimulation (TMS), Transcutaneous Electrical Nerve Stimulation (TENS) and Other External Devices)), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, Other Applications), and Geography (US, Canada, Mexico). The report offers the value (in USD million) for the above segments.

North America Neurostimulation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Neurostimulation Devices Industry Overview

The North America neurostimulation devices market is fragmented in nature. The major companies in the market are focusing on product innovations, expansions, finding new markets, or innovating their core competency to expand their market share. Some of the major players in the neurostimulation devices market are Medtronic, Cyberonics, Boston Scientific Corporation, and Abbott Laboratories, among others.

North America Neurostimulation Devices Market Leaders

  1. Abbott Laboratories

  2. Synapse Biomedical Inc.

  3. Boston Scientific Corporation

  4. NeuroPace Inc.

  5. Nevro Corp.

  6. *Disclaimer: Major Players sorted in no particular order
North America Neurostimulation Devices Market Concentration

North America Neurostimulation Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?